Matthew F.

Matthew F. is an Associate Scientist at Capsida Biotherapeutics, with a focus on qualifying qPCR assays for bio distribution studies, generating performance controls for assays, and maintaining HEK293 cell lines. Previous experience includes roles at Kite Pharma, where Matthew collaborated on assay development and automation initiatives, and Amgen, where responsibilities involved generating AAV vectors and presenting data in a collaborative environment. Prior to these positions, Matthew contributed to clinical research at Cytolumina, collecting data from pancreatic cancer patients, and held various laboratory roles at UCLA. Matthew holds a Master of Science in Biotechnology, Bioinformatics from the University of Maryland Global Campus and dual Bachelor’s degrees in Marine Biology and Biological Oceanography and Biology from UCLA.